Abstract:Ruirui Duan, 1– 4 Hongtao Niu, 2– 4 Tao Yu, 2– 5 Han Cui, 2– 4, 6 Ting Yang, 1– 5 Ke Hao, 7 Chen Wang 1– 4, 6 1 Peking University China-Japan Friendship School of Clinical Medicine, Beijing, People's Republic of China; 2 Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China; 3 National Clinical Research Center for Respiratory Diseases, Beijing, People's Republic of China; 4 Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China; 5 Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, People's Republic of China; 6 Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China; 7 Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA Correspondence: Chen Wang Peking University China-Japan Friendship School of Clinical Medicine, No. 2, East Yinghua Road, Chaoyang District, Beijing 100029, People's Republic of China Tel/ Fax +86-01-8420 6276 Email cyh-birm@263.net Purpose: Circular RNAs (circRNAs) regulate other RNA transcripts by competing for shared microRNAs, which play roles in the pathogenesis of many diseases, including chronic obstructive pulmonary disease (COPD). However, the role of circRNAs in COPD remains unknown. This study aimed to investigate the expression profile and the role of circRNAs in COPD. Patients and Methods: Twenty-one COPD patients and twenty-one normal controls were recruited. Total RNAs were collected from peripheral blood mononuclear cells (PBMCs) of each participant. CircRNAs and protein-coding mRNAs were profiled by microarray and systematically compared between patients with COPD and control subjects. The top differentially expressed circRNAs and mRNAs were validated by quantitative real-time PCR (RT-qPCR). Functional analysis identified pathways relevant to the pathogenesis of COPD. Next, the circRNA target pathway network, the circRNA-miRNA-mRNA network (ceRNA network) and functional ceRNA regulatory modules were constructed. Results: In total, 2132 circRNAs and 2734 protein-coding mRNAs were differentially expressed (|fold change| > 1.5 and P-value < 0.05) in COPD patients. Six out of nine selected RNAs were confirmed by RT-qPCR validation. Our functional analysis suggested that immune imbalances and inflammatory responses play roles in the pathogenesis of COPD. The ceRNA network highlighted the differentially expressed circRNAs and their related miRNAs and mRNAs in COPD. In the circRNA target pathway network and functional ceRNA regulatory modules, hsa_circRNA_0008672 appeared in the top three KEGG pathways (NOD-like receptor signaling pathway, natural killer cell mediated cytotoxicity and Th17 cell differentiation) and may act as the miRNA sponge regulating the hsa_circRNA_0008672/miR-1265/MAPK1 axis. Conclusion: Our findings demonstrate critical roles of the circRNAs in COPD molecular etiology. The data support a plausible mechanism that circRNAs may be involved in the development of COPD by affecting the immune balance. Moreover, the hsa_circRNA_0008672/miR-1265/MAPK1 axis may contribute to the pathogenesis of COPD, warranting further investigation. Keywords: circular RNA, competing endogenous RNAs, chronic obstructive pulmonary disease, expression profile, co-expression network

Analysis of Differentially Expressed circRNAs and mRNAs and Their Correlation Network in Peripheral Blood of COVID-19 Patients

A Study of Differential Circrna and Lncrna Expressions in COVID-19-infected Peripheral Blood

Analysis of Changes in Circular RNA Expression and Construction of Cerna Networks in Human Dilated Cardiomyopathy.

Potential Core Genes Associated with COVID-19 Identified Via Weighted Gene Co-Expression Network Analysis.

Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients

Construction and Investigation of Competing Endogenous RNA Networks and Candidate Genes Involved in SARS-CoV-2 Infection

Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19

Circular RNAs As Emerging Regulators in COVID-19 Pathogenesis and Progression

Circulating microRNAs as emerging regulators of COVID-19.

Non-coding RNAs Expression in SARS-CoV-2 Infection: Pathogenesis, Clinical Significance, and Therapeutic Targets

Identification and Bioinformatic Analysis of Circular RNA Expression in Peripheral Blood Mononuclear Cells from Patients with Chronic Obstructive Pulmonary Disease

Differential microRNA expression in the peripheral blood from human patients with COVID‐19

Plasma cell-free RNA characteristics in COVID-19 patients

Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach

COVID-19 of differing severity: from bulk to single-cell expression data analysis

Bioinformation Analysis of Differential Expression Proteins in Different Processes of COVID-19

Evaluation of the Expression of Infection-Related Long Noncoding RNAs among COVID-19 Patients: A Case-Control Study

Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients

Identification, characterization and expression analysis of circRNA encoded by SARS-CoV-1 and SARS-CoV-2

Identification and characterization of circRNAs encoded by MERS-CoV, SARS-CoV-1 and SARS-CoV-2

Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19